We are live on ! Find out more
IMMU

Immunomedics Inc
IMMU

Delisted

IMMU was delisted on the 22nd of October, 2020.

92 hedge funds and large institutions have $144M invested in Immunomedics Inc in 2015 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 37 increasing their positions, 17 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

233% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 6

118% more repeat investments, than reductions

Existing positions increased: 37 | Existing positions reduced: 17

110% more capital invested

Capital invested by funds: $68.9M → $144M (+$75.4M)

89% more call options, than puts

Call options by funds: $7.47M | Put options by funds: $3.95M

16% more funds holding

Funds holding: 7992 (+13)

Holders
92
Holders Change
+13
Holders Change %
+16.46%
% of All Funds
2.41%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.05%
New
20
Increased
37
Reduced
17
Closed
6
Calls
$7.47M
Puts
$3.95M
Net Calls
+$3.52M
Net Calls Change
+$3.76M
Name Holding Trade Value Shares
Change
Change in
Stake
Charles Schwab
26
Charles Schwab
California
$605K -$118K -42,400 -18%
SW
27
SVB Wealth
Massachusetts
$599K
California State Teachers Retirement System (CalSTRS)
28
California State Teachers Retirement System (CalSTRS)
California
$549K +$8.74K +3,133 +2%
TA
29
Teachers Advisors
New York
$542K -$1.3K -467 -0.3%
D.E. Shaw & Co
30
D.E. Shaw & Co
New York
$522K +$257K +91,917 +118%
Barclays
31
Barclays
United Kingdom
$489K +$374K +134,095 +462%
Connor, Clark & Lunn Investment Management (CC&L)
32
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$465K -$13.1K -4,700 -3%
California Public Employees Retirement System
33
California Public Employees Retirement System
California
$459K
Wells Fargo
34
Wells Fargo
California
$356K +$9.76K +3,498 +3%
Swiss National Bank
35
Swiss National Bank
Switzerland
$351K
AllianceBernstein
36
AllianceBernstein
Tennessee
$348K
RhumbLine Advisers
37
RhumbLine Advisers
Massachusetts
$308K +$2.22K +795 +0.8%
LCP
38
Lamond Capital Partners
California
$307K +$279K +100,000 New
WMSA
39
Weiss Multi-Strategy Advisers
New York
$307K +$279K +100,000 New
State Board of Administration of Florida Retirement System
40
State Board of Administration of Florida Retirement System
Florida
$286K
VEA
41
Virtus ETF Advisers
New York
$284K +$258K +92,480 New
ProShare Advisors
42
ProShare Advisors
Maryland
$277K +$24.5K +8,780 +11%
New York State Common Retirement Fund
43
New York State Common Retirement Fund
New York
$270K
CS
44
Credit Suisse
Switzerland
$259K +$58.5K +20,961 +33%
PC
45
PointState Capital
New York
$246K +$223K +80,000 New
MLICM
46
Metropolitan Life Insurance Company (MetLife)
New York
$229K -$1.33K -475 -0.6%
Deutsche Bank
47
Deutsche Bank
Germany
$226K +$85K +30,460 +70%
Creative Planning
48
Creative Planning
Kansas
$221K +$97.7K +35,000 +95%
Morgan Stanley
49
Morgan Stanley
New York
$219K +$49.8K +17,837 +33%
NFA
50
Nationwide Fund Advisors
Ohio
$198K +$6.32K +2,264 +4%

IMMU Hedge Fund Activity: Q4 2015 in Review

92 of the 3,813 institutional investors tracked by Wall St. Rank reported a position in Immunomedics Inc (IMMU) for Q4 2015, worth a combined $144M — up 110% from $68.9M a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new IMMU positions and 6 closed out — a net gain of 14 holders — while 37 added to existing stakes and 17 trimmed.

The largest buyer was Acuta Capital Partners, adding an estimated $6.29M. The largest seller was Fidelity Investments, cutting an estimated $2.99M.

  • 92 institutional investors held Immunomedics Inc (IMMU) as of Q4 2015, up from 79 in Q3 2015.
  • Funds reported $144M of Immunomedics Inc stock for Q4 2015, up 110% quarter-over-quarter.
  • 20 funds opened new Immunomedics Inc positions in Q4 2015 and 6 closed out, a net change of +14 holders.
  • The largest Immunomedics Inc buyer in Q4 2015 was Acuta Capital Partners, an estimated $6.29M added.
  • The largest Immunomedics Inc seller in Q4 2015 was Fidelity Investments, an estimated $2.99M sold.

Based on aggregated 13F filings for Q4 2015.